Like many large pharmaceutical companies, Bristol Myers Squibb hasn’t made brain drugs a top priority over the last decade.
As a field, neuroscience represents a...
Construction of plasmidsThe whole amino acid sequence of each constructed receptor is shown in Supplementary Information (Supplementary Fig. 1). A backbone plasmid pMK-stuffer-IPTG25 was used...
BOSTON, Sept. 13, 2023 /PRNewswire/ -- CereVasc, LLC, a clinical-stage, medical device company developing novel treatments for neurological diseases, announced that data from...
SEATTLE (BUSINESS WIRE) ‒ Critical Insight, the Cybersecurity-as-a-Service provider specializing in helping critical organizations Prepare, Detect, and Respond in today’s threat environment, today announced the launch...
HAIFA, Israel, Aug. 21, 2023 /PRNewswire/ -- Medical device startup NURAMI MEDICAL has received 510(k) clearance from the US Food and Drug Administration (FDA) for...
Dive Brief:
Stoke Therapeutics on Tuesday revealed study results from a pair of small, mid-stage trials testing a medicine designed to target the underlying cause...
WASHINGTON — As the House Science Committee considers a commercial space bill, industry officials advocated for key topics they believe should be included in...
